Page Image

CIO 2023

Real-world education from the Symposium on Clinical Interventional Oncology 2023, September 22-24, 2023, Orlando, FL, from the editors of GI Oncology Now

Treating Hepatic Tumors With Histotripsy
Treating Hepatic Tumors With Histotripsy
Rob DillardUnresectable HCC | October 6, 2023
Histotripsy is an innovative modality for treating liver tumors that offers several advantages.
Number of Arteries Treated in Patients Undergoing TACE for Hepatocellular Carcinoma
Number of Arteries Treated in Patients Undergoing TACE for Hepatocellular Carcinoma
Rob DillardUnresectable HCC | October 6, 2023
The number of arteries treated during transarterial chemoembolization did not affect outcomes in liver cancer patients.
Radiation Lobectomy With Transarterial Embolization of Yttrium-90 in Hepatocellular Carcinoma
Radiation Lobectomy With Transarterial Embolization of Yttrium-90 in Hepatocellular Carcinoma
Rob DillardUnresectable HCC | October 6, 2023
Radiation lobectomy with transarterial embolization of Yttrium-90 is a viable option for hepatocellular carcinoma.
Long-term Survival Observed in HIMALAYA Study of Durvalumab Plus Tremelimumab for uHCC
Long-term Survival Observed in HIMALAYA Study of Durvalumab Plus Tremelimumab for uHCC
Rob DillardUnresectable HCC | October 6, 2023
Durvalumab plus tremelimumab significantly improved overall survival in patients with unresectable liver cancer.
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy